Tag: BPCIA exclusivity
on Jun 23, 2026
Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
Explore the 12-year biologic patent protection timeline under the BPCIA, the patent dance, and why biosimilars lag behind generics in the U.S. market.